Repligens Q4 Earnings Beat Estimates, Revenues In Line
RGEN reports decent fourth-quarter results and issues guidance for 2025.…
141,100€
2,88%
Echtzeit-Aktienkurs Repligen Corp.
Bid:
Ask:
Nachrichten zur Repligen Corp. Aktie
Repligens Q4 Slightly Tops Expectations
The bioprocessing technology specialists fourth-quarter results were dragged down by restructuring costs.…
After-hours movers: Steelcase, Hess Midstream Partners, Repligen By Investing.com
After-hours movers: Steelcase, Hess Midstream Partners, Repligen…
Maravai Lifesciences Shares Soar After Reported Takeover Offer
Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.…
Repligens (RGEN) Q2 Earnings & Revenues Meet Estimates
Repligens (RGEN) second-quarter earnings and revenues match estimates. The company narrows its revenue guidance for 2024. Stock rises.…